Article content material
VANCOUVER, British Columbia, Nov. 19, 2024 (GLOBE NEWSWIRE) — Ahmad Doroudian broadcasts that he has filed an early warning report (the “Report”) saying his direct and oblique possession of 14,250,461 frequent shares (every, a “Widespread Share”) within the capital of BetterLife Pharma Inc. (the “Firm” or “BetterLife”). Dr. Doroudian’s possession, representing roughly 11.01% of the Firm’s issued and excellent Widespread Shares, is held as an funding based mostly on his long-term views of the Firm. Dr. Doroudian might enhance or lower his curiosity relying on market and different elements and will accomplish that within the open market or by way of non-public transactions.
Share this text in your social community
